Facilitated By

San Antonio Medical Foundation

News

  • Dialectic Therapeutics Announces First-in-Human Dose in Phase 1 Clinical Trial Evaluating ...

    Based in Dallas, Texas, Dialectic has research partners and facilities at UT Health San Antonio and University of Florida Health. Biotech venture investors ...

  • goodblend™ Texas Announces Educational goodblend CannaBus™ Tour Across Texas ...

    ... Houston, and San Antonio, the tour will culminate on November 20 in Houston. ... Through its wholly-owned Parallel Biosciences subsidiary, it conducts ...

  • Cuba's famed Varadero beach getting ready for tourists again - MySA

    ... end of November— taking advantage of its unusually advanced biomedical industry to create the only locally developed COVID-19 vaccines in Latin America.

  • WHO still reviewing Sputnik V vaccine, as Russia presses bid - mySA

    The next vaccine on the group's agenda is one from India's Bharat Biotech, which is expected to be discussed this month. ___. Daria Litvinova in Moscow ...

  • Lululemon, Moderna rise; Comtech, Newmont fall - mySA

    Ocugen Inc., up 18 cents to $6.93. The biopharmaceutical company signed a co-development deal with Bharat Biotech for the COVID-19 vaccine Covaxin. Moderna Inc.